Sign in
CompletedNo phase

Quality of Life and Uremic Toxins in HDx

Key facts

Who runs it
Mackay Memorial Hospital
Where
Taiwan1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
23 people enrolled
Started
1 Mar 2024
Ended
30 Jul 2024
Type of study
Interventional
Treatments tested
  • Medium Cut-Off Dialyzer for Expanded Hemodialysis
Record updated
13 November 2026

Who can take part

Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Adults aged 18 years or older
  • Patients receiving maintenance hemodialysis three times weekly for at least 10 years
  • Ability to provide written informed consent

Who cannot take part

  • Active malignancy
  • Other major organ failure
  • History of major surgery within the preceding 3 months

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Expanded hemodialysis (HDx) is a dialysis treatment designed to improve the removal of certain waste products from the blood. However, its effects on health-related quality of life and blood levels of uremic toxins in patients receiving long-term hemodialysis remain uncertain.

Read full original descriptionShow less

This study aimed to evaluate changes in quality of life and uremic toxin levels after switching from conventional hemodialysis to HDx. Patients who had been receiving maintenance hemodialysis for at least 10 years underwent HDx for three months. Quality of life and blood levels of selected uremic toxins were assessed before and after the treatment period.

The study aimed to determine whether switching to HDx was associated with changes in patients' quality of life and uremic toxin profiles.

The group in the trial

  • Expanded Hemodialysis (HDx)Treatment being tested

    Participants receiving long-term maintenance hemodialysis were switched from conventional hemodialysis to expanded hemodialysis (HDx) using a medium cut-off dialyzer for three months. Hemodialysis was performed three times weekly. Health-related quality of life and uremic toxin levels were assessed at baseline and after the three-month HDx intervention.

    Treatment: Medium Cut-Off Dialyzer for Expanded Hemodialysis

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Changes in Quality of Life and Uremic Toxin Profiles After Switching to Expanded Hemodialysis
Record updated
13 November 2026